Sort
40,608 grants matching “prostate cancer”
Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer
$557,186Jiang He · University Of Virginia · R01 · FY2021 · CA
Transmembrane Proteases and Prostate Carcinogenesis
$557,111Robert Vessella · University Of Washington · P01 · FY2012 · CA
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$557,051Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2015 · CA
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer
$556,991Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2019 · CA
Evaluation of novel treatments in biochemically recurrent prostate
$556,986Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Defining Tumor Microenvironmental Mediators of Prostate Cancer Metastasis and Therapy Resistance
$556,981Paula Jill Hurley · Vanderbilt University Medical Center · R01 · FY2025 · CA
Analytical Biochemistry Shared Resource
$556,929Robert J. Turesky · University Of Minnesota · P30 · FY2019 · CA
Analytical Biochemistry Shared Resource
$556,929Robert J. Turesky · University Of Minnesota · P30 · FY2020 · CA
Analytical Biochemistry Shared Resource
$556,929Robert J. Turesky · University Of Minnesota · P30 · FY2023 · CA
Analytical Biochemistry Shared Resource
$556,929Robert J. Turesky · University Of Minnesota · P30 · FY2022 · CA
Analytical Biochemistry Shared Resource
$556,929Robert J. Turesky · University Of Minnesota · P30 · FY2021 · CA
12-LIPOXYGENASE-INDUCED PROSTATE CANCER REDIORESISTANCE: A PIVOTAL TOLE FOR NF-KAPPAB SIGNALING
$556,928Wayne State University · · FY2011 · Department of the Army
TARGETING CD24 SIGNALING FOR LETHAL METASTATIC PROSTATE CANCER THERAPY
$556,875University Of Alabama At Birmingham · · FY2020 · Defense Health Agency
Targeting B7-H3 in ovarian cancer
$556,817Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
$556,793Christopher J Sweeney · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Prostate Cancer Risk Enhancers
$556,779Peggy J Farnham · University Of Southern California · R01 · FY2017 · CA
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
$556,695Akila Viswanathan · Johns Hopkins University · R01 · FY2020 · CA
Biology of AR+ prostate cancer metastases and the role of the microenvironment
$556,681Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Prostate Cancer Studies
$556,650Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
ASSESSING THE ROLE OF COPY NUMBER VARIANTS IN PROSTATE CANCER RISK AND PROGRESSION USING A NOVEL GENOME-WIDE SCREENING METHOD
$556,612The University Of Texas Health Science Center At San Antonio · · FY2009 · Department of Defense
"Statistical Methods for Genetic Epidemiology"
$556,597Alice S Whittemore · Stanford University · R01 · FY2007 · CA
Natural History of Prostatism: The Olmsted County Study
$556,584Jennifer Lynn St Sauver · Mayo Clinic Rochester · R01 · FY2007 · DK
Screening for Free: A Value-Based Insurance Design Natural Experiment
$556,577John Hsu · Massachusetts General Hospital · R01 · FY2014 · CA
A Nested Case-Control Study of Prostate Carcinogenesis
$556,565Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2011 · ES
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner
$556,458Leanna J Standish · Bastyr University · U19 · FY2010 · AT